| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |